Stem Cell NK Differentiation Without Feeder Cells or Sorting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for differentiating natural killer (NK) cells are time-consuming, requiring 5-6 weeks and involve the use of feeder cells and cell sorting, leading to high costs and inefficiencies.
Innovation Solution
A method involving a series of culture steps with specific growth factors, cytokines, and protein inhibitors, including ROCK inhibitors, BMP-4, FGF2, WNT pathway activators, and Activin A, to differentiate stem cells into NK cells without feeder cells or sorting, reducing the process to approximately 3-4 weeks.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current methods for differentiating NK cells are used, then NK cells can be generated, but the process takes 5-6 weeks and requires feeder cells and cell sorting
Solution Approach 1:
The patent changes the biochemical parameters of the culture medium by specifying precise concentrations of growth factors (IL-2: 10-100 U/mL, IL-15: 10-100 U/mL, IL-7: 1-10 ng/mL), cytokines (SCF: 10-100 ng/mL, FLT3L: 10-100 ng/mL), and small molecule inhibitors (ROCK inhibitor: 1-10 μM, PD0325901: 1-10 μM, SB431542: 1-10 μM). This optimized parameter combination accelerates differentiation while maintaining cell quality, reducing the process from 5-6 weeks to a more efficient timeline without requiring feeder cells or sorting steps.
Solution Approach 2:
The patent extracts and eliminates the requirement for feeder cells and cell sorting from the differentiation process. By using a defined serum-free medium with optimized growth factors and small molecule inhibitors, the method achieves efficient NK cell differentiation without these additional components, thereby reducing complexity, cost, and time while maintaining high cell output.
2Reliability
If feeder cells and cell sorting are used, then NK cell differentiation can be supported, but costs increase and process complexity increases
Solution Approach 1:
The patent implements self-service by using a defined serum-free medium containing optimized concentrations of growth factors and small molecule inhibitors that directly support NK cell differentiation without requiring feeder cells. The medium composition (IL-2, IL-15, IL-7, SCF, FLT3L, ROCK inhibitor, PD0325901, SB431542) creates an environment where cells differentiate efficiently on their own, eliminating the need for additional supporting cell types and reducing process complexity.
Solution Approach 2:
The patent removes feeder cells and cell sorting steps from the differentiation protocol. By extracting these complex components and replacing them with a optimized chemical medium composition, the method maintains reliable differentiation efficiency while significantly simplifying the overall process and reducing costs.
3Productivity
If a defined serum-free medium with optimized growth factors and small molecule inhibitors is used, then differentiation time is reduced and cell output is enhanced, but medium complexity increases
Solution Approach 1:
The patent optimizes medium complexity by precisely defining the concentrations of each component: IL-2 (10-100 U/mL), IL-15 (10-100 U/mL), IL-7 (1-10 ng/mL), SCF (10-100 ng/mL), FLT3L (10-100 ng/mL), ROCK inhibitor (1-10 μM), PD0325901 (1-10 μM), and SB431542 (1-10 μM). This parameter optimization ensures high cell output and reduced differentiation time while maintaining manageable medium complexity through defined, reproducible concentrations rather than undefined serum components.
Data Source
AI summary
The disclosure features methods and compositions for differentiating stem cells into hematopoietic stem and progenitor cells (HSPC) and/or Natural Killer (NK) cells. The methods and compositions described herein are used to differentiate stem or progenitor cells having at least one gene-edit that is maintained in the differentiated cell. Also provided are differentiated cells produced using the methods and compositions described herein for therapeutic applications.